Lincoln National Corp’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-26,128
Closed -$3.35M 780
2024
Q1
$3.35M Buy
26,128
+2,394
+10% +$307K 0.05% 223
2023
Q4
$2.46M Buy
23,734
+5,478
+30% +$567K 0.04% 249
2023
Q3
$1.66M Buy
18,256
+946
+5% +$86K 0.03% 293
2023
Q2
$1.4M Buy
17,310
+1,296
+8% +$105K 0.03% 328
2023
Q1
$1.27M Buy
16,014
+684
+4% +$54.4K 0.03% 333
2022
Q4
$1.04M Buy
15,330
+2,068
+16% +$140K 0.02% 351
2022
Q3
$661K Buy
13,262
+1,074
+9% +$53.5K 0.02% 421
2022
Q2
$679K Buy
12,188
+1,840
+18% +$103K 0.02% 415
2022
Q1
$574K Buy
10,348
+380
+4% +$21.1K 0.01% 480
2021
Q4
$558K Buy
9,968
+5,652
+131% +$316K 0.01% 486
2021
Q3
$207K Sell
4,316
-590
-12% -$28.3K ﹤0.01% 812
2021
Q2
$205K Sell
4,906
-6,020
-55% -$252K ﹤0.01% 807
2021
Q1
$369K Buy
+10,926
New +$369K 0.01% 543
2018
Q1
Sell
-8,402
Closed -$225K 576
2017
Q4
$225K Buy
+8,402
New +$225K 0.01% 574